Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.71 |
| ▸ | HTR1A | P08908 | 3/20 | 0.71 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.71 |
| ▸ | DRD1 | P21728 | 3/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.71 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.71 |
| ▸ | DRD3 | P35462 | 3/20 | 0.71 |
| ▸ | THPO | P40225 | 3/20 | 0.71 |
| ▸ | MTOR | P42345 | 3/20 | 0.71 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.71 |
| ▸ | NPC1 | O15118 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21445198 | 0.89 | TP53 (0.67) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| Ammonia Solution, Strong SCHEMBL6944606 | 0.89 | TP53 (0.71) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| Dimethylamine SCHEMBL7750171 | 0.87 | TP53 (0.69) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| Dimethylamine SCHEMBL7746717 | 0.86 | TP53 (0.68) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL13305160 | 0.86 | TP53 (0.71) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL7346761 | 0.85 | TP53 (0.86) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL20774243 | 0.85 | TP53 (0.67) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| Ammonia Solution, Strong SCHEMBL22186870 | 0.84 | TP53 (0.65) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL13305285 | 0.84 | TP53 (0.79) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL561399 | 0.84 | LMNA (0.75) | TP53MAPK1CYP1A2ABCB1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220024879-A1 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | TWINCORE ZENTRUM FUR EXPERIMENTELLE UND KLINISCHE INFEKTIONSFORSCHUNG GMBH (DE) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024879-A1 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | HAVCR2, HCCS, HELZ | TP53 397/4885MAPK1 3302/4885CYP1A2 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.